These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30358903)

  • 1. Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study.
    Sagmeister MS; Taylor AE; Fenton A; Wall NA; Chanouzas D; Nightingale PG; Ferro CJ; Arlt W; Cockwell P; Hardy RS; Harper L
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):241-249. PubMed ID: 30358903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).
    Mongia A; Vecker R; George M; Pandey A; Tawadrous H; Schoeneman M; Muneyyirci-Delale O; Nacharaju V; Ten S; Bhangoo A
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3622-9. PubMed ID: 22872687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Renal Function Is Associated With Derangement of 11-
    Gant CM; Minovic I; Binnenmars H; de Vries L; Kema I; van Beek A; Navis G; Bakker S; Laverman GD
    J Endocr Soc; 2018 Jul; 2(7):609-620. PubMed ID: 29942925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X; Chen F; Zhu C; Lu Y
    J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition.
    Gómez C; Alimajstorovic Z; Othonos N; Winter DV; White S; Lavery GG; Tomlinson JW; Sinclair AJ; Odermatt A
    Br J Pharmacol; 2024 Mar; 181(5):698-711. PubMed ID: 37740611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig.
    Quinkler M; Troeger H; Eigendorff E; Maser-Gluth C; Stiglic A; Oelkers W; Bähr V; Diederich S
    J Endocrinol; 2003 Feb; 176(2):185-92. PubMed ID: 12553867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric renal allograft transplantation does not normalize the increased cortisol/cortisone ratios of chronic renal failure.
    Schroth M; Plank C; Rauh M; Dörr HG; Rascher W; Dötsch J
    Eur J Endocrinol; 2006 Apr; 154(4):555-61. PubMed ID: 16556718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
    Kerstens MN; Riemens SC; Sluiter WJ; Pratt JJ; Wolthers BG; Dullaart RP
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):403-11. PubMed ID: 10762282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women.
    Rask E; Simonyte K; Lönn L; Axelson M
    Clin Endocrinol (Oxf); 2013 May; 78(5):700-5. PubMed ID: 22233384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.
    Ferrari P; Sansonnens A; Dick B; Frey FJ
    Hypertension; 2001 Dec; 38(6):1330-6. PubMed ID: 11751713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.
    N'Gankam V; Uehlinger D; Dick B; Frey BM; Frey FJ
    Kidney Int; 2002 May; 61(5):1859-66. PubMed ID: 11967038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
    Vogt B; Dick B; N'Gankam V; Frey FJ; Frey BM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):811-4. PubMed ID: 10022459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition.
    Dullaart RP; Ubels FL; Hoogenberg K; Smit AJ; Pratt JJ; Muntinga JH; Sluiter WJ; Wolthers BG
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3002-8. PubMed ID: 7559888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol metabolism in depressed patients and healthy controls.
    Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
    Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.
    Lovati E; Ferrari P; Dick B; Jostarndt K; Frey BM; Frey FJ; Schorr U; Sharma AM
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3745-9. PubMed ID: 10523024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
    Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.
    Campino C; Carvajal CA; Cornejo J; San Martín B; Olivieri O; Guidi G; Faccini G; Pasini F; Sateler J; Baudrand R; Mosso L; Owen GI; Kalergis AM; Padilla O; Fardella CE
    Endocrine; 2010 Feb; 37(1):106-14. PubMed ID: 19882252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.